Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases
dc.contributor.author | Dellavance, A. | |
dc.contributor.author | Alvarenga, R. R. [UNIFESP] | |
dc.contributor.author | Rodrigues, S. H. [UNIFESP] | |
dc.contributor.author | Kok, F. | |
dc.contributor.author | Souza, A. W. S. de [UNIFESP] | |
dc.contributor.author | Andrade, L. E. C. [UNIFESP] | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Fleury Grp | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.date.accessioned | 2016-01-24T14:17:53Z | |
dc.date.available | 2016-01-24T14:17:53Z | |
dc.date.issued | 2012-02-01 | |
dc.description.abstract | Background and purposes: Anti-aquaporin 4 antibodies are specific markers for Devics disease. This study aimed to test if this high specificity holds in the context of a large spectrum of systemic autoimmune and non-autoimmune diseases.Methods: Anti-aquaporin-4 antibodies (NMO-IgG) were determined by indirect immunofluorescence (IIF) on mouse cerebellum in 673 samples, as follows: group I (clinically defined Devic's disease, n = 47); group II [ inflammatory/demyelinating central nervous system (CNS) diseases, n = 41]; group III (systemic and organ-specific autoimmune diseases, n = 250); group IV (chronic or acute viral diseases, n = 35); and group V (randomly selected samples from a general clinical laboratory, n = 300).Results: MNO-IgG was present in 40/47 patients with classic Devic's disease (85.1% sensitivity) and in 13/22 (59.1%) patients with disorders related to Devic's disease. the latter 13 positive samples had diagnosis of longitudinally extensive transverse myelitis (n = 10) and isolated idiopathic optic neuritis (n = 3). One patient with multiple sclerosis and none of the remaining 602 samples with autoimmune and miscellaneous diseases presented NMO-IgG (99.8% specificity). the autoimmune disease subset included five systemic lupus erythematosus individuals with isolated or combined optic neuritis and myelitis and four primary Sjogren's syndrome (SS) patients with cranial/peripheral neuropathy.Conclusions: the available data clearly point to the high specificity of anti-aquaporin-4 antibodies for Devic's disease and related syndromes also in the context of miscellaneous non-neurologic autoimmune and non-autoimmune disorders. | en |
dc.description.affiliation | Universidade Federal de São Paulo, Div Rheumatol, UNIFESP, BR-04023062 São Paulo, Brazil | |
dc.description.affiliation | Fleury Grp, Div Res & Dev, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Dept Neurol, São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Div Rheumatol, UNIFESP, BR-04023062 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Research and Development Division, Fleury Group | |
dc.format.extent | 248-252 | |
dc.identifier | http://dx.doi.org/10.1111/j.1468-1331.2011.03479.x | |
dc.identifier.citation | European Journal of Neurology. Malden: Wiley-Blackwell, v. 19, n. 2, p. 248-252, 2012. | |
dc.identifier.doi | 10.1111/j.1468-1331.2011.03479.x | |
dc.identifier.issn | 1351-5101 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/34608 | |
dc.identifier.wos | WOS:000299255300014 | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | European Journal of Neurology | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://olabout.wiley.com/WileyCDA/Section/id-406071.html | |
dc.subject | AQP4 antibody | en |
dc.subject | aquaporin-4 | en |
dc.subject | myasthenia gravis | en |
dc.subject | neuromyelitis Optica | en |
dc.subject | NMO-IgG | en |
dc.subject | Sjogren's syndrome | en |
dc.subject | systemic lupus erythematosus | en |
dc.title | Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases | en |
dc.type | info:eu-repo/semantics/article |